LITTLE FALLS, N.J., Nov. 1, 2017 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) announced today that its Board of Directors approved an increase in its semiannual cash dividend from $0.07 to $0.085 per outstanding share of the Company's Common Stock. The dividend is payable on January 31, 2018 to shareholders of record at the close of business on January 17, 2018.
"We are pleased to announce the increase in our dividend, which will raise our annual payment from $0.14 to $0.17 per share," stated Charles M. Diker, Chairman of the Board. "This is the 8th consecutive year that we have increased our dividend. The 21% increase is a direct result of the continued success of the Company and demonstrates our confidence in future performance. We're committed to enhancing value for our shareholders and the dividend is an important component."
About Cantel Medical
Cantel Medical is a leading global company dedicated to delivering innovative infection prevention products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products. Additionally, we provide technical service for our products.
For further information, visit the Cantel website at www.cantelmedical.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.
SOURCE Cantel Medical Corp.